Using synthetic genome readers/regulators to interrogate chromatin processes: A brief review.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Philips SJ;Philips SJ; Danda A; Danda A; Ansari AZ; Ansari AZ
  • Source:
    Methods (San Diego, Calif.) [Methods] 2024 May; Vol. 225, pp. 20-27. Date of Electronic Publication: 2024 Mar 11.
  • Publication Type:
    Journal Article; Review; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Academic Press Country of Publication: United States NLM ID: 9426302 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9130 (Electronic) Linking ISSN: 10462023 NLM ISO Abbreviation: Methods Subsets: MEDLINE
    • Publication Information:
      Publication: Duluth, MN : Academic Press
      Original Publication: San Diego : Academic Press, c1990-
    • Subject Terms:
    • Abstract:
      Aberrant gene expression underlies numerous human ailments. Hence, developing small molecules to target and remedy dysfunctional gene regulation has been a long-standing goal at the interface of chemistry and medicine. A major challenge for designing small molecule therapeutics aimed at targeting desired genomic loci is the minimization of widescale disruption of genomic functions. To address this challenge, we rationally design polyamide-based multi-functional molecules, i.e., Synthetic Genome Readers/Regulators (SynGRs), which, by design, target distinct sequences in the genome. Herein, we briefly review how SynGRs access chromatin-bound and chromatin-free genomic sites, then highlight the methods for the study of chromatin processes using SynGRs on positioned nucleosomes in vitro or disease-causing repressive genomic loci in vivo.
      Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: AZA: founder of Vista Motif LLC, Winstep Forward non-profit 501(C) (3) and co-founder of Design Therapeutics. SJP and AD: none.
      (Copyright © 2024 Elsevier Inc. All rights reserved.)
    • References:
      Biochemistry. 1993 Oct 26;32(42):11385-9. (PMID: 8218203)
      Nat Rev Genet. 2016 Aug;17(8):487-500. (PMID: 27346641)
      Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):867-72. (PMID: 16418267)
      Angew Chem Int Ed Engl. 2015 May 26;54(22):6457-61. (PMID: 25873363)
      Nature. 1997 Sep 18;389(6648):251-60. (PMID: 9305837)
      Proc Natl Acad Sci U S A. 2005 Apr 5;102(14):5008-13. (PMID: 15781856)
      Cell. 2015 Jan 15;160(1-2):191-203. (PMID: 25557079)
      Cell Res. 2011 Apr;21(4):564-78. (PMID: 21423274)
      Adv Biochem Eng Biotechnol. 2007;104:65-85. (PMID: 17290819)
      Curr Med Chem. 2001 Apr;8(5):475-508. (PMID: 11281837)
      Elife. 2017 Feb 10;6:. (PMID: 28186491)
      ACS Chem Biol. 2007 Aug 17;2(8):561-71. (PMID: 17708671)
      Nature. 2023 Jan;613(7942):96-102. (PMID: 36517591)
      Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):E7418-E7427. (PMID: 27830652)
      J Mol Biol. 2001 Jun 8;309(3):615-29. (PMID: 11397084)
      Science. 1994 Oct 28;266(5185):646-50. (PMID: 7939719)
      Biochemistry. 2004 Apr 6;43(13):3880-90. (PMID: 15049695)
      Chem Biol. 1996 May;3(5):369-77. (PMID: 8807866)
      J Mol Biol. 2003 Feb 14;326(2):371-80. (PMID: 12559907)
      Nucleic Acids Res. 2009 Dec;37(22):e151. (PMID: 19843614)
      Nature. 1997 May 8;387(6629):202-5. (PMID: 9144294)
      Methods Mol Biol. 2014;1196:255-78. (PMID: 25151169)
      Cell. 2000 Oct 13;103(2):263-71. (PMID: 11057899)
      Curr Opin Chem Biol. 2002 Dec;6(6):765-72. (PMID: 12470729)
      Nucleic Acids Res. 2000 Jan 1;28(1):235-42. (PMID: 10592235)
      Nat Struct Biol. 1998 Feb;5(2):104-9. (PMID: 9461074)
      Curr Opin Struct Biol. 2017 Dec;47:1-8. (PMID: 28349863)
      Bioorg Med Chem Lett. 2009 Jul 15;19(14):3779-82. (PMID: 19435662)
      Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16598-603. (PMID: 19805343)
      Angew Chem Int Ed Engl. 1998 Jun 5;37(10):1421-1423. (PMID: 29710894)
      Science. 1998 Oct 2;282(5386):111-5. (PMID: 9756473)
      J Am Chem Soc. 2012 Oct 24;134(42):17814-22. (PMID: 23013524)
      Methods Enzymol. 2011;497:3-30. (PMID: 21601080)
      Science. 1986 Feb 14;231(4739):699-704. (PMID: 3080805)
      J Am Chem Soc. 2023 Nov 3;:. (PMID: 37923569)
      ACS Chem Biol. 2008 Apr 18;3(4):220-9. (PMID: 18422304)
      J Am Chem Soc. 2018 Jun 13;140(23):7108-7115. (PMID: 29792694)
      Chem Biol. 1997 Aug;4(8):569-78. (PMID: 9281524)
      Chem Biol. 2001 Jun;8(6):583-92. (PMID: 11410377)
      Nature. 1988 Oct 20;335(6192):683-9. (PMID: 3050531)
      J Mol Biol. 1997 Dec 12;274(4):439-45. (PMID: 9417925)
      J Am Chem Soc. 2004 Dec 15;126(49):15940-1. (PMID: 15584709)
      Nature. 1998 Jan 29;391(6666):468-71. (PMID: 9461213)
      Nucleic Acids Res. 2016 May 19;44(9):4014-24. (PMID: 27098039)
      J Am Chem Soc. 2003 Nov 5;125(44):13322-3. (PMID: 14583004)
      Proc Natl Acad Sci U S A. 2018 Nov 6;115(45):E10586-E10595. (PMID: 30341220)
      Cell. 2013 Jan 17;152(1-2):327-39. (PMID: 23332764)
      Proc Natl Acad Sci U S A. 2004 May 4;101(18):6864-9. (PMID: 15100411)
      J Vis Exp. 2016 Jan 20;(107):e53510. (PMID: 26863565)
      Proc Natl Acad Sci U S A. 2010 Mar 9;107(10):4544-9. (PMID: 20176964)
      Biochimie. 2008 Jul;90(7):1015-25. (PMID: 18343232)
      Proc Natl Acad Sci U S A. 2004 Nov 30;101(48):16768-73. (PMID: 15556999)
      Biomater Sci. 2014 Mar 3;2(3):297-307. (PMID: 32481858)
      Genome Res. 2010 Jun;20(6):861-73. (PMID: 20378718)
      Mol Cancer Ther. 2013 May;12(5):675-84. (PMID: 23443804)
      Proc Natl Acad Sci U S A. 1985 Mar;82(5):1376-80. (PMID: 2983343)
      Nat Commun. 2023 Jul 13;14(1):4179. (PMID: 37443151)
      J Am Chem Soc. 2002 Nov 6;124(44):13067-71. (PMID: 12405833)
      Bioorg Med Chem. 2001 Sep;9(9):2215-35. (PMID: 11553460)
      Cell. 1985 Dec;43(3 Pt 2):729-36. (PMID: 3907859)
      Nature. 2000 Jan 6;403(6765):41-5. (PMID: 10638745)
      J Mol Biol. 1998 Feb 13;276(1):19-42. (PMID: 9514715)
      Mol Cell. 2020 Jun 18;78(6):1086-1095. (PMID: 32407673)
      Adv Drug Deliv Rev. 2019 Jul;147:66-85. (PMID: 30742856)
      Cell. 2011 Sep 16;146(6):1016-28. (PMID: 21925322)
      Angew Chem Int Ed Engl. 2014 Sep 15;53(38):10124-8. (PMID: 25066383)
      Nucleic Acids Res. 2019 May 7;47(8):3828-3835. (PMID: 30838415)
      J Mol Biol. 1997 Sep 26;272(3):301-11. (PMID: 9325091)
      PLoS One. 2020 Dec 22;15(12):e0243905. (PMID: 33351840)
      Proc Natl Acad Sci U S A. 2009 Aug 11;106(32):13175-9. (PMID: 19666554)
      Nature. 1996 Aug 8;382(6591):559-61. (PMID: 8700233)
      Angew Chem Int Ed Engl. 2007;46(16):2865-8. (PMID: 17351994)
      J Am Chem Soc. 2007 Oct 10;129(40):12310-9. (PMID: 17880081)
      Biochemistry. 1992 Nov 17;31(45):10969-75. (PMID: 1445835)
      J Am Chem Soc. 2007 Mar 7;129(9):2660-8. (PMID: 17290996)
      Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):3930-5. (PMID: 10760265)
      Med Chem Res. 2020 Apr;29(4):607-616. (PMID: 34552311)
      EMBO Rep. 2015 Nov;16(11):1467-81. (PMID: 26474904)
      Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7586-90. (PMID: 1323845)
      Methods Enzymol. 1999;304:3-19. (PMID: 10372352)
      Science. 2017 Dec 22;358(6370):1617-1622. (PMID: 29192133)
    • Grant Information:
      R01 NS108376 United States NS NINDS NIH HHS
    • Contributed Indexing:
      Keywords: COSMIC; CSI; DiSEL; Genome-targeting; Nucleosome; Polyamide; SEL; SynGR; Synthetic transcription factors; Transcription
    • Accession Number:
      0 (Chromatin)
      0 (Nucleosomes)
      0 (Nylons)
    • Publication Date:
      Date Created: 20240312 Date Completed: 20240426 Latest Revision: 20240429
    • Publication Date:
      20240429
    • Accession Number:
      PMC11055675
    • Accession Number:
      10.1016/j.ymeth.2024.03.001
    • Accession Number:
      38471600